nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—MAPT—amyotrophic lateral sclerosis	0.533	1	CbGaD
Paclitaxel—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.184	1	CbGbCtD
Paclitaxel—Red blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0618	CcSEcCtD
Paclitaxel—Cabazitaxel—TUBA4A—amyotrophic lateral sclerosis	0.00387	0.658	CrCbGaD
Paclitaxel—Peritonitis—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0282	CcSEcCtD
Paclitaxel—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0273	CcSEcCtD
Paclitaxel—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0191	CcSEcCtD
Paclitaxel—MAP2—nerve—amyotrophic lateral sclerosis	0.00205	0.0445	CbGeAlD
Paclitaxel—Docetaxel—MAPT—amyotrophic lateral sclerosis	0.00202	0.342	CrCbGaD
Paclitaxel—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0174	CcSEcCtD
Paclitaxel—MAP4—hindbrain—amyotrophic lateral sclerosis	0.00195	0.0423	CbGeAlD
Paclitaxel—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0143	CcSEcCtD
Paclitaxel—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0143	CcSEcCtD
Paclitaxel—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0139	CcSEcCtD
Paclitaxel—MAP2—hindbrain—amyotrophic lateral sclerosis	0.00153	0.0333	CbGeAlD
Paclitaxel—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0117	CcSEcCtD
Paclitaxel—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0113	CcSEcCtD
Paclitaxel—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0112	CcSEcCtD
Paclitaxel—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0112	CcSEcCtD
Paclitaxel—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0111	CcSEcCtD
Paclitaxel—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0109	CcSEcCtD
Paclitaxel—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0107	CcSEcCtD
Paclitaxel—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0105	CcSEcCtD
Paclitaxel—MAP4—embryo—amyotrophic lateral sclerosis	0.00122	0.0264	CbGeAlD
Paclitaxel—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0104	CcSEcCtD
Paclitaxel—TUBB4A—hindbrain—amyotrophic lateral sclerosis	0.00119	0.0257	CbGeAlD
Paclitaxel—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0101	CcSEcCtD
Paclitaxel—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0101	CcSEcCtD
Paclitaxel—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0101	CcSEcCtD
Paclitaxel—MAP4—brainstem—amyotrophic lateral sclerosis	0.00112	0.0242	CbGeAlD
Paclitaxel—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00962	CcSEcCtD
Paclitaxel—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00954	CcSEcCtD
Paclitaxel—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0093	CcSEcCtD
Paclitaxel—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00922	CcSEcCtD
Paclitaxel—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00914	CcSEcCtD
Paclitaxel—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00886	CcSEcCtD
Paclitaxel—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.001	0.00865	CcSEcCtD
Paclitaxel—MAPT—medulla oblongata—amyotrophic lateral sclerosis	0.00099	0.0215	CbGeAlD
Paclitaxel—MAP2—embryo—amyotrophic lateral sclerosis	0.00096	0.0208	CbGeAlD
Paclitaxel—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00816	CcSEcCtD
Paclitaxel—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.000932	0.00805	CcSEcCtD
Paclitaxel—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00788	CcSEcCtD
Paclitaxel—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00788	CcSEcCtD
Paclitaxel—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00783	CcSEcCtD
Paclitaxel—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00778	CcSEcCtD
Paclitaxel—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00767	CcSEcCtD
Paclitaxel—MAPT—spinal cord—amyotrophic lateral sclerosis	0.000883	0.0192	CbGeAlD
Paclitaxel—MAP2—brainstem—amyotrophic lateral sclerosis	0.000879	0.0191	CbGeAlD
Paclitaxel—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.000871	0.00753	CcSEcCtD
Paclitaxel—TUBB8—nervous system—amyotrophic lateral sclerosis	0.000857	0.0186	CbGeAlD
Paclitaxel—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00729	CcSEcCtD
Paclitaxel—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00725	CcSEcCtD
Paclitaxel—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00721	CcSEcCtD
Paclitaxel—TUBB8—central nervous system—amyotrophic lateral sclerosis	0.000826	0.0179	CbGeAlD
Paclitaxel—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00712	CcSEcCtD
Paclitaxel—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00712	CcSEcCtD
Paclitaxel—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00712	CcSEcCtD
Paclitaxel—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.000819	0.00708	CcSEcCtD
Paclitaxel—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00695	CcSEcCtD
Paclitaxel—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00687	CcSEcCtD
Paclitaxel—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000787	0.0068	CcSEcCtD
Paclitaxel—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00676	CcSEcCtD
Paclitaxel—MAP4—medulla oblongata—amyotrophic lateral sclerosis	0.000779	0.0169	CbGeAlD
Paclitaxel—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000757	0.00654	CcSEcCtD
Paclitaxel—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000745	0.00644	CcSEcCtD
Paclitaxel—TUBB4A—embryo—amyotrophic lateral sclerosis	0.000742	0.0161	CbGeAlD
Paclitaxel—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00624	CcSEcCtD
Paclitaxel—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00618	CcSEcCtD
Paclitaxel—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00618	CcSEcCtD
Paclitaxel—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00606	CcSEcCtD
Paclitaxel—MAPT—cerebellum—amyotrophic lateral sclerosis	0.0007	0.0152	CbGeAlD
Paclitaxel—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000694	0.006	CcSEcCtD
Paclitaxel—MAP4—spinal cord—amyotrophic lateral sclerosis	0.000694	0.0151	CbGeAlD
Paclitaxel—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00594	CcSEcCtD
Paclitaxel—TUBB4A—brainstem—amyotrophic lateral sclerosis	0.00068	0.0147	CbGeAlD
Paclitaxel—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000669	0.00578	CcSEcCtD
Paclitaxel—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00066	0.0057	CcSEcCtD
Paclitaxel—TUBB8—brain—amyotrophic lateral sclerosis	0.000655	0.0142	CbGeAlD
Paclitaxel—Injury—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00562	CcSEcCtD
Paclitaxel—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000634	0.00548	CcSEcCtD
Paclitaxel—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000631	0.00545	CcSEcCtD
Paclitaxel—MAP2—medulla oblongata—amyotrophic lateral sclerosis	0.000613	0.0133	CbGeAlD
Paclitaxel—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000613	0.0053	CcSEcCtD
Paclitaxel—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00519	CcSEcCtD
Paclitaxel—TUBB3—nervous system—amyotrophic lateral sclerosis	0.000585	0.0127	CbGeAlD
Paclitaxel—MAP4—nervous system—amyotrophic lateral sclerosis	0.000585	0.0127	CbGeAlD
Paclitaxel—TUBB4B—embryo—amyotrophic lateral sclerosis	0.000578	0.0126	CbGeAlD
Paclitaxel—TUBB1—nervous system—amyotrophic lateral sclerosis	0.000572	0.0124	CbGeAlD
Paclitaxel—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000569	0.00491	CcSEcCtD
Paclitaxel—MAPT—brain—amyotrophic lateral sclerosis	0.000569	0.0123	CbGeAlD
Paclitaxel—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000567	0.0049	CcSEcCtD
Paclitaxel—TUBB3—central nervous system—amyotrophic lateral sclerosis	0.000563	0.0122	CbGeAlD
Paclitaxel—MAP4—central nervous system—amyotrophic lateral sclerosis	0.000563	0.0122	CbGeAlD
Paclitaxel—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000563	0.00486	CcSEcCtD
Paclitaxel—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000556	0.00481	CcSEcCtD
Paclitaxel—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000552	0.00477	CcSEcCtD
Paclitaxel—TUBB1—central nervous system—amyotrophic lateral sclerosis	0.000551	0.012	CbGeAlD
Paclitaxel—MAP4—cerebellum—amyotrophic lateral sclerosis	0.000551	0.0119	CbGeAlD
Paclitaxel—TUBB3—cerebellum—amyotrophic lateral sclerosis	0.000551	0.0119	CbGeAlD
Paclitaxel—MAP2—spinal cord—amyotrophic lateral sclerosis	0.000547	0.0119	CbGeAlD
Paclitaxel—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00472	CcSEcCtD
Paclitaxel—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000545	0.0047	CcSEcCtD
Paclitaxel—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00467	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00465	CcSEcCtD
Paclitaxel—BCL2—nervous system—amyotrophic lateral sclerosis	0.000532	0.0115	CbGeAlD
Paclitaxel—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000528	0.00456	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000528	0.00456	CcSEcCtD
Paclitaxel—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000521	0.0045	CcSEcCtD
Paclitaxel—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000517	0.00447	CcSEcCtD
Paclitaxel—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000517	0.00447	CcSEcCtD
Paclitaxel—BCL2—central nervous system—amyotrophic lateral sclerosis	0.000512	0.0111	CbGeAlD
Paclitaxel—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000507	0.00438	CcSEcCtD
Paclitaxel—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000497	0.0043	CcSEcCtD
Paclitaxel—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00424	CcSEcCtD
Paclitaxel—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00418	CcSEcCtD
Paclitaxel—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00418	CcSEcCtD
Paclitaxel—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00413	CcSEcCtD
Paclitaxel—TUBB4A—medulla oblongata—amyotrophic lateral sclerosis	0.000474	0.0103	CbGeAlD
Paclitaxel—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00408	CcSEcCtD
Paclitaxel—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00407	CcSEcCtD
Paclitaxel—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00404	CcSEcCtD
Paclitaxel—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000464	0.00401	CcSEcCtD
Paclitaxel—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00398	CcSEcCtD
Paclitaxel—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00398	CcSEcCtD
Paclitaxel—MAP2—nervous system—amyotrophic lateral sclerosis	0.000461	0.01	CbGeAlD
Paclitaxel—Depression—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00397	CcSEcCtD
Paclitaxel—TUBB2B—medulla oblongata—amyotrophic lateral sclerosis	0.000458	0.00994	CbGeAlD
Paclitaxel—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000455	0.00393	CcSEcCtD
Paclitaxel—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000452	0.0039	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000452	0.0039	CcSEcCtD
Paclitaxel—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00388	CcSEcCtD
Paclitaxel—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00387	CcSEcCtD
Paclitaxel—MAP4—brain—amyotrophic lateral sclerosis	0.000447	0.00971	CbGeAlD
Paclitaxel—TUBB3—brain—amyotrophic lateral sclerosis	0.000447	0.00971	CbGeAlD
Paclitaxel—MAP2—central nervous system—amyotrophic lateral sclerosis	0.000444	0.00963	CbGeAlD
Paclitaxel—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00044	0.0038	CcSEcCtD
Paclitaxel—TUBB1—brain—amyotrophic lateral sclerosis	0.000437	0.00949	CbGeAlD
Paclitaxel—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00377	CcSEcCtD
Paclitaxel—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000435	0.00376	CcSEcCtD
Paclitaxel—MAP2—cerebellum—amyotrophic lateral sclerosis	0.000434	0.00941	CbGeAlD
Paclitaxel—TUBB—medulla oblongata—amyotrophic lateral sclerosis	0.000433	0.00941	CbGeAlD
Paclitaxel—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00374	CcSEcCtD
Paclitaxel—TUBB2A—medulla oblongata—amyotrophic lateral sclerosis	0.000431	0.00936	CbGeAlD
Paclitaxel—TUBB6—medulla oblongata—amyotrophic lateral sclerosis	0.000425	0.00923	CbGeAlD
Paclitaxel—TUBB4A—spinal cord—amyotrophic lateral sclerosis	0.000423	0.00917	CbGeAlD
Paclitaxel—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000421	0.00364	CcSEcCtD
Paclitaxel—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000416	0.00359	CcSEcCtD
Paclitaxel—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000415	0.00358	CcSEcCtD
Paclitaxel—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00358	CcSEcCtD
Paclitaxel—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00356	CcSEcCtD
Paclitaxel—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00355	CcSEcCtD
Paclitaxel—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00353	CcSEcCtD
Paclitaxel—TUBB2B—spinal cord—amyotrophic lateral sclerosis	0.000408	0.00886	CbGeAlD
Paclitaxel—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00352	CcSEcCtD
Paclitaxel—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00351	CcSEcCtD
Paclitaxel—BCL2—brain—amyotrophic lateral sclerosis	0.000407	0.00882	CbGeAlD
Paclitaxel—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000406	0.0035	CcSEcCtD
Paclitaxel—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00338	CcSEcCtD
Paclitaxel—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00334	CcSEcCtD
Paclitaxel—TUBB—spinal cord—amyotrophic lateral sclerosis	0.000386	0.00839	CbGeAlD
Paclitaxel—TUBB2A—spinal cord—amyotrophic lateral sclerosis	0.000384	0.00834	CbGeAlD
Paclitaxel—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000384	0.00332	CcSEcCtD
Paclitaxel—TUBB6—spinal cord—amyotrophic lateral sclerosis	0.000379	0.00823	CbGeAlD
Paclitaxel—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000376	0.00324	CcSEcCtD
Paclitaxel—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00323	CcSEcCtD
Paclitaxel—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00322	CcSEcCtD
Paclitaxel—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.000372	0.00808	CbGeAlD
Paclitaxel—Chills—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00321	CcSEcCtD
Paclitaxel—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00319	CcSEcCtD
Paclitaxel—TUBB4B—medulla oblongata—amyotrophic lateral sclerosis	0.00037	0.00802	CbGeAlD
Paclitaxel—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000366	0.00316	CcSEcCtD
Paclitaxel—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00313	CcSEcCtD
Paclitaxel—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00311	CcSEcCtD
Paclitaxel—TUBB4A—nervous system—amyotrophic lateral sclerosis	0.000356	0.00773	CbGeAlD
Paclitaxel—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00307	CcSEcCtD
Paclitaxel—Tension—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00305	CcSEcCtD
Paclitaxel—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00305	CcSEcCtD
Paclitaxel—MAP2—brain—amyotrophic lateral sclerosis	0.000352	0.00764	CbGeAlD
Paclitaxel—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00302	CcSEcCtD
Paclitaxel—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000349	0.00301	CcSEcCtD
Paclitaxel—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00299	CcSEcCtD
Paclitaxel—TUBB2B—nervous system—amyotrophic lateral sclerosis	0.000344	0.00747	CbGeAlD
Paclitaxel—TUBB4A—central nervous system—amyotrophic lateral sclerosis	0.000343	0.00744	CbGeAlD
Paclitaxel—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000338	0.00292	CcSEcCtD
Paclitaxel—TUBB4A—cerebellum—amyotrophic lateral sclerosis	0.000335	0.00727	CbGeAlD
Paclitaxel—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00289	CcSEcCtD
Paclitaxel—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00288	CcSEcCtD
Paclitaxel—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.000332	0.0072	CbGeAlD
Paclitaxel—TUBB2B—central nervous system—amyotrophic lateral sclerosis	0.000331	0.00719	CbGeAlD
Paclitaxel—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00286	CcSEcCtD
Paclitaxel—TUBB4B—spinal cord—amyotrophic lateral sclerosis	0.00033	0.00715	CbGeAlD
Paclitaxel—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00284	CcSEcCtD
Paclitaxel—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000325	0.00281	CcSEcCtD
Paclitaxel—TUBB2A—nervous system—amyotrophic lateral sclerosis	0.000324	0.00703	CbGeAlD
Paclitaxel—TUBB2B—cerebellum—amyotrophic lateral sclerosis	0.000324	0.00703	CbGeAlD
Paclitaxel—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000324	0.0028	CcSEcCtD
Paclitaxel—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000323	0.00279	CcSEcCtD
Paclitaxel—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000323	0.00279	CcSEcCtD
Paclitaxel—TUBB6—nervous system—amyotrophic lateral sclerosis	0.000319	0.00693	CbGeAlD
Paclitaxel—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000318	0.00275	CcSEcCtD
Paclitaxel—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00274	CcSEcCtD
Paclitaxel—Cough—Riluzole—amyotrophic lateral sclerosis	0.000314	0.00272	CcSEcCtD
Paclitaxel—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000312	0.0027	CcSEcCtD
Paclitaxel—TUBB2A—central nervous system—amyotrophic lateral sclerosis	0.000312	0.00677	CbGeAlD
Paclitaxel—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000311	0.00269	CcSEcCtD
Paclitaxel—TUBB6—central nervous system—amyotrophic lateral sclerosis	0.000308	0.00668	CbGeAlD
Paclitaxel—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00265	CcSEcCtD
Paclitaxel—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00265	CcSEcCtD
Paclitaxel—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00265	CcSEcCtD
Paclitaxel—TUBB—cerebellum—amyotrophic lateral sclerosis	0.000306	0.00665	CbGeAlD
Paclitaxel—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00264	CcSEcCtD
Paclitaxel—TUBB2A—cerebellum—amyotrophic lateral sclerosis	0.000305	0.00662	CbGeAlD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00263	CcSEcCtD
Paclitaxel—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000303	0.00262	CcSEcCtD
Paclitaxel—TUBB6—cerebellum—amyotrophic lateral sclerosis	0.000301	0.00652	CbGeAlD
Paclitaxel—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00259	CcSEcCtD
Paclitaxel—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000297	0.00256	CcSEcCtD
Paclitaxel—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00254	CcSEcCtD
Paclitaxel—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00254	CcSEcCtD
Paclitaxel—Infection—Riluzole—amyotrophic lateral sclerosis	0.000292	0.00252	CcSEcCtD
Paclitaxel—Shock—Riluzole—amyotrophic lateral sclerosis	0.000289	0.0025	CcSEcCtD
Paclitaxel—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000288	0.00249	CcSEcCtD
Paclitaxel—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000288	0.00249	CcSEcCtD
Paclitaxel—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00248	CcSEcCtD
Paclitaxel—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000286	0.00247	CcSEcCtD
Paclitaxel—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00246	CcSEcCtD
Paclitaxel—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00242	CcSEcCtD
Paclitaxel—TUBB4B—nervous system—amyotrophic lateral sclerosis	0.000278	0.00603	CbGeAlD
Paclitaxel—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000275	0.00237	CcSEcCtD
Paclitaxel—TUBB4A—brain—amyotrophic lateral sclerosis	0.000272	0.00591	CbGeAlD
Paclitaxel—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000268	0.00231	CcSEcCtD
Paclitaxel—TUBB4B—central nervous system—amyotrophic lateral sclerosis	0.000267	0.0058	CbGeAlD
Paclitaxel—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000266	0.0023	CcSEcCtD
Paclitaxel—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000264	0.00228	CcSEcCtD
Paclitaxel—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.000263	0.00571	CbGeAlD
Paclitaxel—TUBB2B—brain—amyotrophic lateral sclerosis	0.000263	0.00571	CbGeAlD
Paclitaxel—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00226	CcSEcCtD
Paclitaxel—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00226	CcSEcCtD
Paclitaxel—TUBB4B—cerebellum—amyotrophic lateral sclerosis	0.000261	0.00567	CbGeAlD
Paclitaxel—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000259	0.00224	CcSEcCtD
Paclitaxel—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000256	0.00221	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00219	CcSEcCtD
Paclitaxel—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00219	CcSEcCtD
Paclitaxel—Pain—Riluzole—amyotrophic lateral sclerosis	0.000251	0.00217	CcSEcCtD
Paclitaxel—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000251	0.00217	CcSEcCtD
Paclitaxel—TUBB—brain—amyotrophic lateral sclerosis	0.000249	0.0054	CbGeAlD
Paclitaxel—TUBB2A—brain—amyotrophic lateral sclerosis	0.000248	0.00537	CbGeAlD
Paclitaxel—TUBB6—brain—amyotrophic lateral sclerosis	0.000244	0.0053	CbGeAlD
Paclitaxel—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000242	0.00209	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00024	0.00208	CcSEcCtD
Paclitaxel—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000235	0.00511	CbGeAlD
Paclitaxel—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00202	CcSEcCtD
Paclitaxel—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00201	CcSEcCtD
Paclitaxel—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00201	CcSEcCtD
Paclitaxel—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.000227	0.00492	CbGeAlD
Paclitaxel—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.00022	0.00477	CbGeAlD
Paclitaxel—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000218	0.00473	CbGeAlD
Paclitaxel—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000217	0.00187	CcSEcCtD
Paclitaxel—ABCC10—brain—amyotrophic lateral sclerosis	0.000214	0.00464	CbGeAlD
Paclitaxel—TUBB4B—brain—amyotrophic lateral sclerosis	0.000212	0.00461	CbGeAlD
Paclitaxel—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000212	0.0046	CbGeAlD
Paclitaxel—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000211	0.00182	CcSEcCtD
Paclitaxel—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000208	0.0018	CcSEcCtD
Paclitaxel—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000207	0.00449	CbGeAlD
Paclitaxel—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000201	0.00174	CcSEcCtD
Paclitaxel—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000194	0.00168	CcSEcCtD
Paclitaxel—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000194	0.00422	CbGeAlD
Paclitaxel—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000187	0.00162	CcSEcCtD
Paclitaxel—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000186	0.00404	CbGeAlD
Paclitaxel—Rash—Riluzole—amyotrophic lateral sclerosis	0.000185	0.0016	CcSEcCtD
Paclitaxel—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000185	0.0016	CcSEcCtD
Paclitaxel—Headache—Riluzole—amyotrophic lateral sclerosis	0.000184	0.00159	CcSEcCtD
Paclitaxel—CYP19A1—brain—amyotrophic lateral sclerosis	0.00018	0.0039	CbGeAlD
Paclitaxel—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000175	0.00151	CcSEcCtD
Paclitaxel—ABCB1—embryo—amyotrophic lateral sclerosis	0.000168	0.00365	CbGeAlD
Paclitaxel—CYP1B1—brain—amyotrophic lateral sclerosis	0.000168	0.00365	CbGeAlD
Paclitaxel—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000154	0.00335	CbGeAlD
Paclitaxel—ABCC1—brain—amyotrophic lateral sclerosis	0.000151	0.00328	CbGeAlD
Paclitaxel—CYP2C8—brain—amyotrophic lateral sclerosis	0.000129	0.00279	CbGeAlD
Paclitaxel—ABCG2—brain—amyotrophic lateral sclerosis	0.000125	0.00272	CbGeAlD
Paclitaxel—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000114	0.00248	CbGeAlD
Paclitaxel—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00011	0.00238	CbGeAlD
Paclitaxel—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000107	0.00233	CbGeAlD
Paclitaxel—ABCB1—spinal cord—amyotrophic lateral sclerosis	9.59e-05	0.00208	CbGeAlD
Paclitaxel—ABCB1—nervous system—amyotrophic lateral sclerosis	8.08e-05	0.00175	CbGeAlD
Paclitaxel—ABCB1—central nervous system—amyotrophic lateral sclerosis	7.78e-05	0.00169	CbGeAlD
Paclitaxel—ABCB1—cerebellum—amyotrophic lateral sclerosis	7.6e-05	0.00165	CbGeAlD
Paclitaxel—ABCB1—brain—amyotrophic lateral sclerosis	6.17e-05	0.00134	CbGeAlD
Paclitaxel—BCL2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	2.62e-05	0.000227	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000226	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	2.6e-05	0.000225	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.000224	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.58e-05	0.000223	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	2.55e-05	0.000221	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—amyotrophic lateral sclerosis	2.55e-05	0.000221	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—DCTN1—amyotrophic lateral sclerosis	2.54e-05	0.00022	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.54e-05	0.00022	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.54e-05	0.00022	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.53e-05	0.00022	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.53e-05	0.000219	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.52e-05	0.000219	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	2.49e-05	0.000216	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.000216	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.48e-05	0.000215	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.48e-05	0.000215	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	2.48e-05	0.000215	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.45e-05	0.000212	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.45e-05	0.000212	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.44e-05	0.000212	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.000211	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.000211	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	2.41e-05	0.000209	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	2.41e-05	0.000209	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.36e-05	0.000205	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.36e-05	0.000204	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.35e-05	0.000204	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.34e-05	0.000203	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.33e-05	0.000202	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.27e-05	0.000197	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.27e-05	0.000197	CbGpPWpGaD
Paclitaxel—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.24e-05	0.000194	CbGpPWpGaD
Paclitaxel—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.23e-05	0.000193	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.22e-05	0.000193	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.22e-05	0.000192	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.21e-05	0.000191	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.21e-05	0.000191	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.2e-05	0.000191	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	2.2e-05	0.000191	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.18e-05	0.000189	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—VEGFA—amyotrophic lateral sclerosis	2.17e-05	0.000188	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.16e-05	0.000187	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.16e-05	0.000187	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.16e-05	0.000187	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	2.14e-05	0.000186	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.14e-05	0.000185	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.13e-05	0.000185	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.13e-05	0.000184	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	2.09e-05	0.000181	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.07e-05	0.000179	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.05e-05	0.000178	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000175	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.01e-05	0.000174	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	2e-05	0.000173	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	2e-05	0.000173	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	1.98e-05	0.000171	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.97e-05	0.000171	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.94e-05	0.000168	CbGpPWpGaD
Paclitaxel—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.000168	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.93e-05	0.000167	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	1.93e-05	0.000167	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	1.93e-05	0.000167	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—amyotrophic lateral sclerosis	1.93e-05	0.000167	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.92e-05	0.000166	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GSR—amyotrophic lateral sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	1.81e-05	0.000157	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	1.8e-05	0.000156	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000156	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—C3—amyotrophic lateral sclerosis	1.77e-05	0.000154	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	1.76e-05	0.000152	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	1.74e-05	0.000151	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	1.74e-05	0.000151	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	1.74e-05	0.000151	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000147	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.64e-05	0.000142	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.63e-05	0.000141	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.63e-05	0.000141	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	1.62e-05	0.000141	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	1.61e-05	0.00014	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.6e-05	0.000139	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	1.59e-05	0.000138	CbGpPWpGaD
Paclitaxel—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000137	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.56e-05	0.000135	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.56e-05	0.000135	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	1.54e-05	0.000133	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000132	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ATF1—amyotrophic lateral sclerosis	1.52e-05	0.000132	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000132	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.52e-05	0.000132	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.5e-05	0.00013	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.48e-05	0.000128	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000128	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.46e-05	0.000127	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.46e-05	0.000126	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CASP9—amyotrophic lateral sclerosis	1.45e-05	0.000126	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000126	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.42e-05	0.000123	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000122	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000121	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.39e-05	0.000121	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.39e-05	0.000121	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.38e-05	0.00012	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.37e-05	0.000119	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.35e-05	0.000117	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.000115	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	1.32e-05	0.000114	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.31e-05	0.000114	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.31e-05	0.000114	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.3e-05	0.000113	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.00011	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB4—amyotrophic lateral sclerosis	1.24e-05	0.000108	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.24e-05	0.000107	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000107	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.000107	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.23e-05	0.000106	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.23e-05	0.000106	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.22e-05	0.000106	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.21e-05	0.000105	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.2e-05	0.000104	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	1.16e-05	0.0001	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	9.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	9.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.14e-05	9.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.12e-05	9.73e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.12e-05	9.68e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.11e-05	9.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.09e-05	9.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.06e-05	9.16e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	9.11e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.05e-05	9.11e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	9.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.04e-05	9.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.04e-05	9.03e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.04e-05	9e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—C3—amyotrophic lateral sclerosis	1.03e-05	8.95e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.01e-05	8.79e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.01e-05	8.77e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	8.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1e-05	8.67e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.85e-06	8.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	9.82e-06	8.51e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.55e-06	8.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	9.54e-06	8.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	9.5e-06	8.23e-05	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—amyotrophic lateral sclerosis	9.14e-06	7.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	8.88e-06	7.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	8.81e-06	7.63e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.72e-06	7.56e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	8.41e-06	7.29e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	8.27e-06	7.16e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.21e-06	7.11e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	8.17e-06	7.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.1e-06	7.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.1e-06	7.02e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.01e-06	6.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	7.63e-06	6.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.59e-06	6.57e-05	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	7.57e-06	6.56e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.54e-06	6.54e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	7.41e-06	6.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	7.23e-06	6.27e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.2e-06	6.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.2e-06	6.24e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	7.2e-06	6.24e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.17e-06	6.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.95e-06	6.02e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.94e-06	6.01e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—amyotrophic lateral sclerosis	6.93e-06	6e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.89e-06	5.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.73e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	6.65e-06	5.76e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	6.59e-06	5.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	6.47e-06	5.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.44e-06	5.58e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	6.26e-06	5.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	6.21e-06	5.38e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	6.21e-06	5.38e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.19e-06	5.37e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.17e-06	5.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.96e-06	5.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.85e-06	5.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.72e-06	4.95e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.69e-06	4.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.67e-06	4.91e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.65e-06	4.9e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	5.57e-06	4.82e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.48e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.46e-06	4.73e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.43e-06	4.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.38e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	5.1e-06	4.42e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.99e-06	4.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.94e-06	4.28e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.86e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.68e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	4.66e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.65e-06	4.03e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.52e-06	3.92e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	4.51e-06	3.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.44e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.25e-06	3.68e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	4.1e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.09e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	4.07e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.92e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.89e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	3.81e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.57e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-06	2.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.36e-06	2.91e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.21e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.19e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.19e-06	2.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.09e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.09e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.94e-06	2.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.93e-06	2.54e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	2.44e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.79e-06	2.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.74e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.7e-06	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.55e-06	2.21e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.52e-06	2.18e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.22e-06	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.07e-06	1.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.01e-06	1.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.81e-06	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.74e-06	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.66e-06	1.44e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.52e-06	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-06	1.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.37e-06	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.36e-07	8.11e-06	CbGpPWpGaD
